ALAN CELIK et al. Impact of age and comorbidities on real-world outcomes in advanced breast cancer patients treated with palbociclib in first line: a nation-wide Danish retrospective study. Acta Oncologica, [S. l.], v. 64, p. 778–783, 2025. DOI: 10.2340/1651-226X.2025.43226. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/43226. Acesso em: 22 apr. 2026.